SIRT6 and breast carcinoma: Increased SIRT6 expression has been reported in pancreatic, prostate and breast cancers, where high SIRT6 levels are associated with chemotherapy resistance and poor prognosis (Bauer et al., 2012; Khongkow et al., 2013; Liu et al., 2013b).